MedPath

Efficacy Study of Vaginal Mesh for Prolapse

Not Applicable
Completed
Conditions
Rectocele
Uterine Prolapse
Vaginal Prolapse
Cystocele
Pelvic Organ Prolapse
Interventions
Device: synthetic monofilament polypropylene mesh
Registration Number
NCT00475540
Lead Sponsor
Medstar Health Research Institute
Brief Summary

The primary aim of this double-blind, randomized clinical trial (RCT) is to test the hypothesis that the addition of a standardized technique of interpositional synthetic polypropylene mesh placement improves the one-year outcome of vaginal reconstructive surgery for pelvic organ prolapse compared to traditional vaginal reconstructive surgery without mesh.

Detailed Description

Minimally invasive surgical procedures using mesh have rapidly developed in the field of pelvic floor reconstruction. Unfortunately, safety and efficacy data have lagged behind the technical advancements. No randomized controlled trials of different vaginal apical suspension procedures have been reported. The use of synthetic vaginal mesh has evolved due to the 20-30% recurrence rate for conventional pelvic reconstructive surgeries. This trial will examine synthetic monofilament polypropylene mesh use in vaginal reconstructive surgery for vaginal Stage II-IV prolapse.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
65
Inclusion Criteria
  • Woman > 21 yrs
  • Stage II-IV vaginal prolapse
  • Desires vaginal reconstructive surgery
  • Able to complete study questionnaires and assessments
  • Uterus < 12 weeks size
  • Available for 12 months follow-up
Exclusion Criteria
  • Medical contraindications, e.g. current urinary tract, vaginal or pelvic infection, history of pelvic irradiation, history of lower urinary tract malignancy, chronic steroid use or a compromised immune system.
  • Current intermittent catheterization.
  • Pregnancy or desire for future fertility.
  • Presence of an adnexal mass.
  • Shortened vagina or other known Mullerian anomaly (e.g. uterine didelphys).
  • Other laparoscopic or abdominal/pelvic surgery in the past 3 months.
  • Known neurologic or medical condition affecting bladder function, e.g. Multiple Sclerosis, spinal cord injury.
  • Need for concomitant surgery requiring an abdominal incision.
  • < 12 months post-partum.
  • Non-english speaking

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Prolift meshsynthetic monofilament polypropylene meshvaginal prolapse repair with mesh
Prolapse repair without meshsynthetic monofilament polypropylene meshvaginal prolapse repair without mesh
Primary Outcome Measures
NameTimeMethod
Number of Participants With Anatomic Cure at 3 Years3 year

3 different measures for Anatomic cure using POPQ measurements:

1. POP-Q at Stage I or less\* (POP-Q points Ba, Bp or C -1 or less);

2. no prolapse beyond the hymen (Ba, Bp or C 0 or less);

3. no prolapse beyond the hymen (Ba, Bp 0 or less) with adequate apical support above the midvagina (C to TVL/2 or less) No bulge symptoms using Pelvic Floor Distress Inventory, PFDI question 3; do you see or feel a bulge in the vaginal area with response of no.

Patient Satisfaction using Patient Global Impression of Improvement with response of very much better or much better

Secondary Outcome Measures
NameTimeMethod
Bothersome Dyspareunia3 year

Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire question 5 response of usually or always and tracked resolution, persistence, de novo dyspareunia

Trial Locations

Locations (1)

Washington Hospital Center

🇺🇸

Washington, District of Columbia, United States

© Copyright 2025. All Rights Reserved by MedPath